- Home
- RDHL vs EVAX Comparison
RDHL vs EVAX Comparison
Compare RDHL & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDHL
- EVAX
- Stock Information
- Founded
- RDHL 2009
- EVAX 2008
- Country
- RDHL Israel
- EVAX Denmark
- Employees
- RDHL N/A
- EVAX N/A
- Industry
- RDHL Biotechnology: Pharmaceutical Preparations
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RDHL Health Care
- EVAX Health Care
- Exchange
- RDHL Nasdaq
- EVAX Nasdaq
- Market Cap
- RDHL 4.3M
- EVAX 10.8M
- IPO Year
- RDHL N/A
- EVAX 2021
- Fundamental
- Price
- RDHL $2.10
- EVAX $2.49
- Analyst Decision
- RDHL
- EVAX Strong Buy
- Analyst Count
- RDHL 0
- EVAX 2
- Target Price
- RDHL N/A
- EVAX $10.00
- AVG Volume (30 Days)
- RDHL 18.8K
- EVAX 94.2K
- Earning Date
- RDHL 08-28-2025
- EVAX 08-13-2025
- Dividend Yield
- RDHL N/A
- EVAX N/A
- EPS Growth
- RDHL N/A
- EVAX N/A
- EPS
- RDHL N/A
- EVAX N/A
- Revenue
- RDHL $8,042,999.00
- EVAX $3,293,000.00
- Revenue This Year
- RDHL $381.91
- EVAX N/A
- Revenue Next Year
- RDHL N/A
- EVAX N/A
- P/E Ratio
- RDHL N/A
- EVAX N/A
- Revenue Growth
- RDHL 23.17
- EVAX 2555.64
- 52 Week Low
- RDHL $1.71
- EVAX $1.20
- 52 Week High
- RDHL $20.28
- EVAX $17.75
- Technical
- Relative Strength Index (RSI)
- RDHL 61.27
- EVAX 54.62
- Support Level
- RDHL $2.00
- EVAX $2.26
- Resistance Level
- RDHL $2.08
- EVAX $2.60
- Average True Range (ATR)
- RDHL 0.09
- EVAX 0.22
- MACD
- RDHL 0.03
- EVAX -0.03
- Stochastic Oscillator
- RDHL 100.00
- EVAX 52.38
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
About EVAX Evaxion Biotech
Evaxion AS is in the field of oncology. It used the AI-Immunology platform.